2025 annual financial data
BioLineRx 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -684.24%.
Operating income was -10,368,606 USD and net income was -1,184,321 USD.
Operating cash flow was -8,138,050 USD.
Get free BioLineRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,189,360 USD
- Operating income
- -10,368,606 USD
- Net income
- -1,184,321 USD
- Operating cash flow
- -8,138,050 USD